HPR144 TNF-Alfa Inhibitor Biosimilars: Qualitative Analysis of Uptake Determinants in Southern European Hospital Markets
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1273
https://www.valueinhealthjournal.com/article/S1098-3015(22)03478-7/fulltext
Title :
HPR144 TNF-Alfa Inhibitor Biosimilars: Qualitative Analysis of Uptake Determinants in Southern European Hospital Markets
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03478-7&doi=10.1016/j.jval.2022.09.1273
First page :
Section Title :
Open access? :
No
Section Order :
10818